food and drug administration fda news

FDA Approves 1st New Schizophrenia Drug in Decades

Regeneron-Sanofi Drug Wins FDA Approval To Treat COPD

Shares of Regeneron Pharmaceuticals and Sanofi edged higher Friday after their drug to treat chronic obstructive pulmonary disease received approval from the Food and Drug Administration.

Reason on MSN · 34m

In a Victory for the Free Market, FDA Approves New Schizophrenia Drug

The U.S. Food and Drug Administration (FDA) approved a novel antipsychotic schizophrenia drug late Thursday, marking the first new treatment in decades for the mental health condition that affects 1.8 percent of the U.

Time on MSN · 8h

FDA Approves the First New Schizophrenia Drug in Decades

Developed by Karuna Therapeutics, which was subsequently acquired by Bristol Myers Squibb, the drug works in an entirely different way from existing medications for schizophrenia, which is building excitement and enthusiasm among doctors and patients alike.

Salmonella and Listeria Found in 2 Pet Food Brands

YAHOO!News · 1d

FDA issues recall notices for two brands of pet food over salmonella and listeria contamination

Pet owners are advised to throw away the at-risk products safely, so pets and children can't access and ingest them

USA TODAY on MSN · 1d

ANSWERS Pet Food recalled over salmonella, listeria concerns: What pet owners need to know

ANSWERS Pet Food is voluntarily recalling several of its products due to potential salmonella and listeria exposure, according to the FDA.

CNET · 5h

Salmonella and Listeria Found in 2 Pet Food Brands: Everything to Know

While one brand has withdrawn the affected products, a second, Darwin's Natural Pet Products, has not, according to the FDA.

FDA Lifts Clinical Hold On BMF-219

Reuters on MSN · 22h

US FDA lifts clinical hold on Biomea's diabetes trials after safety review

The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for type 1 and type 2 diabetes, the drug developer said on Thursday. The regulator had placed a hold on two trials of its lead drug,

Business Insider · 17h

Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up

Biomea Fusion Inc. (BMEA) announced that the U.S. Food and Drug Administration has lifted the clinical hold on the company's ongoing

MarketWatch · 1d

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug. The FDA in June put the biopharmaceutical company's trials on hold,

STAT53m

The FDA is ‘making sandwiches,’ ‘breakfast salad’ in DC, and what keeps us from choking on food

Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up here. In a new ...

6mOpinion

Column: A federal appeals court hands the FDA a stupendous win in its battle against stem cell clinics

The FDA claimed these clinics were plying patients with an illegal drug derived from their stem cells. A federal court agrees ...

HealthDay on MSN4h

FDA Approves New Kind of Drug for Schizophrenia

The first new type of medication in decades to help fight against schizophrenia was approved on Thursday by the U.S. Food and ...

Dog food pulled from shelves nationwide: FDA

The U.S. Food and Drug Administration reports a pet food company is voluntarily withdrawing some of their beef and chicken ...

FDA Approves New Schizophrenia Drug in 70-Year First

The treatment offers hope to thousands of patients who do not respond to existing medications, and has shown promise in treating other neurological disorders.

20h

FDA approves new schizophrenia drug

The U.S. Food and Drug Administration has approved a new drug for adults with schizophrenia, the FDA announced Thursday.

Check Your Fact on MSN3d

FACT CHECK: No, The Food And Drug Administration Did Not Say Mpox Is Fictional

A post shared on X claims the U.S. Food and Drug Administration (FDA) believes the mpox virus, or “monkeypox,” is fictional. Verdict: False The document cited in the article does not make this claim.

12hon MSN

Bristol-Myers Squibb stock jumps on schizophrenia drug approval

Bristol-Myers Squibb shares rose in premarket trade on Friday after the Food and Drug Administration approved a schizophrenia ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results